- 100 Springdale Rd Ste A3 #157 Cherry Hill, New Jersey 08003 United States
- info@kenx.org
- 858 649 3251
Seats are limited. Registration closes as soon as capacity is reached.
Four focused hours on what regulators now expect from AI-enabled systems, and how to build governance and validation evidence that holds up in an inspection.
Bringing your team? Contact info@kenx.org to ask about our team discount.
Seats are limited to keep the session interactive.
The regulatory ground under AI in regulated environments moved fast. Quality and validation teams are being asked for governance, evidence, and answers they were never asked for before.
FDA draft guidance sets a risk-based credibility framework for AI supporting regulatory decisions on safety, efficacy, and quality.
Joint FDA and EMA principles extend that thinking across the full medicines lifecycle, from research to post-market.
FDA issues its first warning letter explicitly citing AI misuse as a GxP compliance violation in pharmaceutical manufacturing.
AI in medical devices and critical health infrastructure is classified high risk, adding a binding layer alongside GxP.
Built from the sessions that drew the most discussion at the KENX AI in GxP conference series, condensed into a working curriculum.
The current landscape in plain terms: FDA guidance, FDA and EMA joint principles, Annex 11 and 22 direction, and the EU AI Act. What enforcement so far tells you about where inspectors will look first.
Establishing intended use as your governance anchor. Classifying AI systems by risk and context of use, defining ownership and escalation paths across IT, QA, and the business, and building an AI system inventory that survives scrutiny.
Writing acceptance criteria for systems that do not behave deterministically. Making intelligent systems testable and defensible, qualifying SaaS and IaaS platforms underneath them, and assessing third-party and supplier risk.
Life after go-live: monitoring and observability, continuous validation, AI-driven audit trail review, and a practical methodology for auditing AI systems. Closes with a live Q&A on the questions your own program is stuck on.
Every attendee receives a working toolkit, not just slides.
Written for practitioners and the leaders who have to sign off on their work. No coding or data science background required.
Quality, IT and regulatory leaders from regulated manufacturers, teaching the material they presented on stage. No vendor pitches.

Sr. Director, GRC CSO and Tech Operations, GSK
Leads governance, risk and compliance for global digital and technology operations. Presented on the GSK AI initiative: building and scaling multi-agent AI systems in practice.

Head of Enterprise GxP IT Systems Quality, Incyte
Presented on defining ownership and accountability for AI across GxP, and on risk-based assurance for AI-enabled systems.

Associate Director, IT Security, Risk and Quality, Gilead
Presented on defining acceptance criteria for AI validation: making intelligent systems testable, defensible and inspection-ready.

Associate Director, Software Quality Assurance & Risk Management, Guardant Health
Presented on interrogating the normal operation of AI systems in GxP: monitoring, observability and operational assurance beyond initial validation.
Live access to all four modules, the full takeaway toolkit, and the session recording afterward.
Register one seatBringing your team? Contact info@kenx.org to ask about our team discount.
Contact NowLarger group rates available. KENX does not issue refunds; registrations may be applied to a future KENX event or transferred to a colleague with at least seven days notice.
No. This is a standalone training course, not a credential. There is no exam and nothing to maintain. You leave with material you can apply to your own program immediately.
Yes. Registered attendees receive access to the recording afterward, so a scheduling conflict on the day does not cost you the content.
No. The course is written for quality, validation, and regulatory professionals. The AI concepts are explained from the ground up, in the language of GxP.
The conference is peer exchange: case studies, practitioner panels, and the room. This is a taught curriculum with a defined syllabus and a toolkit you apply back at your own site.
Four hours that change how your team handles AI in a regulated environment.
Welcome, orientation, and how to get the most from the session
Stephen J. Cook, Sr. Director, GRC CSO and Tech Operations, GSK
Subhabrata Purakayastha, Head of Enterprise GxP IT Systems Quality, Incyte
Abhishek Bachchan, Associate Director, IT Security, Risk and Quality, Gilead
Raj Muthireddy, Associate Director, Software Quality Assurance & Risk Management, Guardant Health
GSK, Incyte, Gilead and Guardant Health
Bring the question your own program is stuck on. Submit questions in advance at registration and we will work through as many as time allows.
